Regenerative treatments that target the cellular and inflammatory roots of metabolic disease, supporting insulin sensitivity, vascular health, and organ function.
Metabolic disease covers a wide range of conditions, from insulin resistance and prediabetes to type 2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). These conditions share a common root cause: the gradual breakdown of how cells produce and use energy. This is often made worse by excess body fat, gut dysfunction, and inactivity. Together, they make up the most common chronic disease burden in the modern world.
Chronic systemic inflammation is the common thread across all of these conditions. People with metabolic disease have elevated levels of inflammatory molecules in their blood. These molecules block the body's response to insulin, damage blood vessel walls, and accelerate organ damage over time. Managing blood sugar alone does not resolve this inflammation. If the root biology is not addressed, the problem keeps getting worse.
Conventional treatments do a good job managing symptoms like blood glucose, blood pressure, and cholesterol. But they do not fix the underlying inflammation or cellular energy problems driving the disease. Regenerative medicine targets these root causes, introducing healing signals that can reduce inflammation, support insulin-producing cells, promote liver health, and restore healthy blood vessel function.
Our protocols are designed to support patients across the metabolic disease spectrum. Each approach is based on the latest evidence for each condition.
Type 2 diabetes involves progressive insulin resistance and stress on the cells that produce insulin. Over time, it causes serious complications throughout the body. Early clinical studies show MSC therapy can improve blood sugar control and lower HbA1c by reducing inflammation in the pancreas and surrounding tissue.
Metabolic syndrome is a cluster of cardiovascular risk factors including belly fat, abnormal cholesterol, high blood pressure, and elevated blood sugar. It reflects widespread inflammation in fat tissue and blood vessels. Regenerative protocols aim to reduce this inflammation and support healthier blood vessel function.
Non-alcoholic fatty liver disease is driven by liver inflammation, fat buildup, and progressive scarring. MSC-derived healing signals have shown promise in supporting liver cell regeneration and reducing liver inflammation in early studies, potentially slowing disease progression.
Persistent fatigue in people with metabolic disease is often rooted in poor cellular energy production and ongoing inflammation, not just lifestyle factors. Exosome-based protocols deliver healing signals that support cellular energy systems and reduce the inflammatory load driving fatigue.
Each protocol is built around your lab results and tailored to your specific health profile.
Before designing your plan, we run a full baseline evaluation including blood sugar markers, insulin levels, inflammation markers, lipid panel, and liver function tests. This data tells us where your metabolism stands and helps us choose the right approach.
Based on your labs and health history, our team builds an IV MSC or exosome protocol tailored to your metabolic profile, organ function, and goals. We determine the right dose, cell source, and session schedule at this stage.
Treatment is given by intravenous infusion in an outpatient setting, typically over one to three sessions spaced four to eight weeks apart. The procedure is well-tolerated and does not require hospitalization or extended recovery.
We run repeat lab panels at weeks eight and sixteen after treatment to track your metabolic response, assess changes in inflammation and blood sugar markers, and adjust your plan as needed. Ongoing communication with our team supports continuity of care.
Metabolic improvement happens gradually. The following is a general framework. Individual results vary based on your starting health, how closely you follow the protocol, and lifestyle factors.
Systemic inflammation begins to settle. Some patients notice improved energy and less persistent fatigue as the initial anti-inflammatory response kicks in.
Insulin sensitivity markers begin showing measurable improvement. Vascular tone and cholesterol levels may show early positive changes as healing signals continue to work.
Blood sugar markers and metabolic lab results often show measurable progress at this stage. Patients frequently report improved energy, better weight stability, and reduced symptoms.
Metabolic markers continue to improve. Most benefit is realized and maintained with appropriate lifestyle management and ongoing clinical monitoring.
Regenerative metabolic protocols are designed for a specific patient profile. The following criteria guide our evaluation process.
Talk with our clinical team to find out if regenerative therapy is right for your metabolic condition and goals.
Book a Consultation